Upcoming and Past Presentations

Upcoming and Past Presentations

Presentations

Advanced Non-Melanoma Skin Cancer in Veterans: Incorporating Advances in Immune Checkpoint Inhibitors to Optimize Outcomes

At this live CME course developed and produced by Plexus Communication, Dr. Miller explores key clinical practice insights for patients with advanced Non-Melanoma Skin Cancer

David M. Miller

A Tailored Approach to Non-Melanoma Skin Cancers: Managing the High-Risk Patient With Systemic Immune-Activating Therapy

At the 2025 ACMS meeting Drs. Miller and Patel discuss pearls in managing the high-risk patient with systemic immune-activating therapy

David M. Miller, Vishal A. Patel

The Evolving Treatment Landscape of Non-Melanoma Skin Cancer: Implications for Dermatology

At the GW School of Medicine Dermatology Grand Rounds, Dr. Miller provides an overview of the evolving treatment landscape of CSCC and its implications for dermatologists

David M. Miller

Merkel Cell Carcinoma Current Concepts in Diagnosis and Management

At a GW Dermatology resident lecutre in Washington D.C., Dr. Miller provides an overview of the current concepts in diagnosis and management of Merkel Cell Carcinoma

David M. Miller

Merkel Cell Carcinoma Current Concepts in Diagnosis and Management

At the 17th Annual UNC Conference on Melanoma and Complex Skin Cancers: A Multidisciplinary Perspective, and part of the Millis-Copeland Endowed Melanoma Lecture, Dr. Miller provides pearls on the current concepts in diagnosis and management of Merkel Cell Carcinoma

David M. Miller

Peri-Operative Management of CSCC

At the 17th Annual UNC Conference on Melanoma and Complex Skin Cancers: A Multidisciplinary Perspective, and part of the Millis-Copeland Endowed Melanoma Lecture, Dr. Miller provides pearls on the current concepts in perioperative management of Cutaneous Squamous Cell Carcinoma

David M. Miller

Society of Cutaneous Oncology Journal Club

At this live Society of Cutaneous Oncology Journal Club, Dr. Miller leads a discussion on the recently published CheckMate-358

David M. Miller

Advanced Non-Melanoma Skin Cancer in Veterans: Incorporating Advances in Immune Checkpoint Inhibitors to Optimize Outcomes

At this live CME course developed and produced by Plexus Communication, Dr. Miller explores key clinical practice insights for patients with advanced Non-Melanoma Skin Cancer

David M. Miller

Peri-operative Management of High-Risk CSCC

At the 2025, American Academy of Dermatology Annual Meeting ‘What’s New in the Management of Advanced Skin Cancer’ session, Dr. Miller provides pearls on the peri-operative management of high-risk CSCC

David M. Miller

Narrowing Nonmelanoma Skin Cancer Gaps With Neoadjuvant Immunotherapy: Multidisciplinary Strategies for Success

At a AiCME program held at the 2025 American Academy of Dermatology Annual Meeting, Drs. Miller and Patel explore key clinical practice insights for patients with high-risk resectable NMSC

David M. Miller, Vishal Patel

Society of Cutaneous Oncology Journal Club

At this live Society of Cutaneous Oncology Journal Club, Dr. Miller leads a discussion on ctDNA in MCC

David M. Miller

Advanced Non-Melanoma Skin Cancer in Veterans: Incorporating Advances in Immune Checkpoint Inhibitors to Optimize Outcomes

This program will explore key clinical practice insights for patients with advanced Non-Melanoma Skin Cancer

David M. Miller

Controversies in Gene Expression Profiling

ODAC Dermatology, Aesthetic & Surgical Conference “General Session”

David M. Miller

Immunotherapy for CSCC - What Dermatologists Should Know

ODAC Dermatology, Aesthetic & Surgical Conference “General Session”

David M. Miller

Collaborative Approaches to Optimize Basal Cell Carcinoma Care Within the Community

Management Pearls for Advanced BCC

David M. Miller

The Evolving Treatment Landscape for CSCC

Reflections on the evolving treatment landscape for CSCC

David M. Miller

Advanced Non-Melanoma Skin Cancer in Veterans: Incorporating Advances in Immune Checkpoint Inhibitors to Optimize Outcomes

This program will explore key clinical practice insights for patients with advanced Non-Melanoma Skin Cancer

David M. Miller

Optimizing Melanoma Outcomes in Rural and Underserved Communities: Adapting to Evolving Treatment Paradigms

We summarize the clinical evidence for the efficacy and safety of new and emerging therapeutic options and treatment strategies for cutaneous melanoma

David M. Miller

Update in the Management of Advanced Cutaneous Squamous Cell Carcinoma

This live program will explore key clinical practice insights for patients with advanced CSCC

David M. Miller

Update in the Management of Non-Resectable Melanoma

This live program will explore key clinical practice insights for patients with non-resectable melanoma

David M. Miller

Shifting the Approach to Nonmelanoma Skin Cancer in Dermatology

This live program will explore key clinical practice insights for patients with advanced Non-Melanoma Skin Cancer

David M. Miller

Advanced Non-Melanoma Skin Cancer in Veterans: Incorporating Advances in Immune Checkpoint Inhibitors to Optimize Outcomes

This program will explore key clinical practice insights for patients with advanced Non-Melanoma Skin Cancer

David M. Miller

A Clinician’s Roadmap to Improving Outcomes in Advanced Basal Cell Carcinoma: Guiding Principles for the Use of Immunotherapies

This program will explore key clinical practice insights for patients with advanced basal cell carcinoma

David M. Miller, Todd Schlessinger

Incorporating Multidisciplinary Care and Immunotherapy to Achieve Optimal Outcomes in Patients With Nonmelanoma Skin Cancers

This HoloVision program will explore key clinical practice insights for patients with advanced or metastatic basal cell or cutaneous squamous cell carcinomas

David M. Miller

Should Ipilimumab Be the New “Standard” for Refractory MCC?

We discuss the role of Ipilimumab in anti-PD1 refractory MCC

David M. Miller